Kizu Hiroto, Takayama Teruhiko, Tsushima Hiroyuki, Noguchi Atsushi, Nakajima Kenichi, Onoguchi Masahisa, Kinuya Seigo
Department of Health Sciences, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
J Nucl Med Technol. 2008 Dec;36(4):186-8. doi: 10.2967/jnmt.108.051656. Epub 2008 Nov 13.
(131)I-metaiodobenzylguanidine (MIBG) has been used as a therapeutic agent for pheochromocytoma. Tumor localization and precise staging are essential for therapy with high-dose (131)I-MIBG. The sites and extent of (123)I-MIBG uptake are usually estimated to predict the effectiveness of therapy before administration. However, conventional scintigraphic images provide insufficient anatomic information. Therefore, we tried to manually superimpose (123)I-MIBG SPECT and CT images using free software.
(131)碘间位碘代苄胍(MIBG)已被用作嗜铬细胞瘤的治疗药物。肿瘤定位和精确分期对于高剂量(131)I-MIBG治疗至关重要。在给予(123)I-MIBG之前,通常通过估计其摄取部位和范围来预测治疗效果。然而,传统的闪烁扫描图像提供的解剖信息不足。因此,我们尝试使用免费软件手动叠加(123)I-MIBG单光子发射计算机断层扫描(SPECT)和计算机断层扫描(CT)图像。